Aytu BioPharma (AYTU)

Data from SEC filings
Employee count
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
The 2022 annual meeting of stockholders for Aytu BioPharma, Inc. was held on May 18, 2022 (the “2022 Annual Meeting”). Of the 33,355,935 shares outstanding on the record date for the meeting, a total of 20,034,954 shares were present or represented at the meeting. The matters voted on and the results of the votes at the 2022 Annual Meeting are as follows:
1.Our stockholders elected five members to our board of directors as follows:

Number of Votes Cast ForNumber of Votes WithheldNumber of Broker Non-Votes
Joshua R. Disbrow7,950,4903,552,9018,531,563
Gary V. Cantrell7,694,4803,808,9118,531,563
Carl C. Dockery7,512,8203,990,5718,531,563
John A. Donofrio, Jr.7,684,8063,818,5858,531,563
Michael E. Macaluso8,029,7993,473,5928,531,563

2.The ratification of the appointment of Plante & Moran, PLLC as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2022 was approved with 16,596,117 votes in favor, 2,811,766 votes against and 627,071 abstentions.
3.The advisory vote on executive compensation was approved with 7,386,646 votes in favor, 3,985,791 votes against and 130,954 abstentions. There were 8,531,563 broker non-votes.
4.The advisory vote on the frequency with which future advisory votes on executive compensation should be held was had 5,841,439 votes for one year, 95,286 votes for two years, 5,309,518 votes for three years and 257,148 abstentions.

In light of these results, notwithstanding its previous recommendation in the proxy statement for the 2022 Annual Meeting, the Company’s Board of Directors determined that the Company will hold future Say-on-Pay votes on an annual basis until the occurrence of the next advisory vote on the frequency of Say-on-Pay votes. The next advisory vote regarding the frequency of Say-on-Pay votes is required to occur no later than the Company’s 2028 Annual Meeting of Stockholders.